Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03642054 · ClinicalTrials.gov registry record
Advanced Biomarker Assessment in Pelvic Organ Prolapse
A clinical trial of Pelvic Organ Prolapse, sponsored by Mayo Clinic.
- Completed
- Registry status
- 18
- Enrollment target
- 1
- Study location
NCT03642054 is a study of Pelvic Organ Prolapse that has completed, run by Mayo Clinic. The registered enrollment target is 18 participants, below the 145-participant average among 40 other Pelvic Organ Prolapse trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03642054, a study of Pelvic Organ Prolapse, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will assess advanced biomarkers in patients with and without vaginal prolapse. Assessments will be directed at vaginal fibroblasts and adipose derived stem cells.
Conditions Studied
Study Locations (1)
Arizona
- Mayo Clinic in Arizona - Phoenix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2018-06-29 |
| Est. Completion | 2020-05-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03642054
The ClinicalTrials.gov registry entry for NCT03642054 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 145-participant average among 40 other Pelvic Organ Prolapse trials with a reported enrollment target (88% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pelvic Organ Prolapse appearing as the primary indexed condition, and to 0 interventions.
NCT03642054 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.
Frequently Asked Questions
What is clinical trial NCT03642054 about?
NCT03642054 is a clinical study titled "Advanced Biomarker Assessment in Pelvic Organ Prolapse". This study will assess advanced biomarkers in patients with and without vaginal prolapse. Assessments will be directed at vaginal fibroblasts and adipose derived stem cells.
What is the current status of trial NCT03642054?
This trial is currently completed. The enrollment target is 18 participants. The study started on 2018-06-29. Estimated completion is 2020-05-18.
What conditions does trial NCT03642054 study?
This clinical trial studies the following conditions: Pelvic Organ Prolapse.
Who is sponsoring clinical trial NCT03642054?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03642054 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pelvic Organ Prolapse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Centered Surgery - Preoperative Counseling and Patient Satisfaction
RECRUITING
-
Ethicon Pelvic Mesh Post Market Clinical Follow-up Registry
RECRUITING
-
Pessary Experience Study
RECRUITING
-
SORE Study: Sitz Baths After Urogynecologic Reconstruction
RECRUITING · NA
-
POMEGRANATE Trial: Comparing Reia Pessary Versus Standard of Care Pessary for Pelvic Organ Prolapse Treatment
RECRUITING · NA
-
Sequence of Midurethral Sling Placement During Robotic Sacrocolpopexy
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.